Jean-marie M. Boher
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.
Journal: Cancer communications (London, England)
Published: November 23, 2025
Stratifying Risk and Treatment Benefit: A Model Predicting Overall Survival in Men with Metastatic De Novo Hormone-sensitive Prostate Cancer in Trials Investigating Docetaxel (the STOPCAP Collaboration).
Journal: European urology focus
Published: November 09, 2025
The plasma nanoDSF denaturation profiles predict the presence of breast cancer.
Journal: Journal of translational medicine
Published: September 26, 2025
Bayesian Estimation of the Binomial Parameter in Adaptive Designs With Treatment Selection.
Journal: Statistics in medicine
Published: February 20, 2025
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.
Journal: European journal of haematology
Published: April 03, 2024
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study.
Journal: BMJ open
Published: March 29, 2024
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC Trial.
Journal: Cancers
Published: February 06, 2024
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Journal: The Lancet. Oncology
Published: March 14, 2023
Is MRI-Linac helpful in SABR treatments for liver cancer?
Journal: Frontiers in oncology
Published: December 23, 2022
Last Updated: 09/26/2026